SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001385508-23-000039
Filing Date
2023-02-07
Accepted
2023-02-07 16:48:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A opiantdefa14a2_7x23.htm DEFA14A 69715
  Complete submission text file 0001385508-23-000039.txt   70885
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38193 | Film No.: 23595756
SIC: 2834 Pharmaceutical Preparations